RT @DrYukselUrun@twitter.com

🔶Adjuvant abemaciclib reduces the risk of recurrence in patients with hormone receptor (+), HER2(-), node-positive, high-risk early #BreastCancer
🔶Serious AEs 15·5%
🔶Most common G 3–4 AE neutropenia 19·6%
@OncoAlert@twitter.com @SABCSSanAntonio@twitter.com #SABCS #SABCS2022
https://doi.org/10.1016/S1470-2045(22)00694-5

🐦🔗: https://twitter.com/DrYukselUrun/status/1600233075455143937

Welcome to San Antonio fellow #bcsm friends!

#SABCS

Anyone going to the an Antonio Breast Cancer Symposium (SABCS)? #SABCS #breastcancer